Randomly 50% N-acetylated low molecular weight chitosan as a novel renal targeting carrier

Journal of Drug Targeting

Volumn 15, Issue 4, 2007, Pages 269-278

  Yuan, Zhi Xiang ^a   Sun, Xun ^a   Gong, Tao ^a   Ding, Hong ^a   Fu, Yao ^a   Zhang, Zhi Rong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Drug delivery; Prednisolone conjugate; Randomly 50 N acetylated low molecular weight chitosan (LMWC); Renal targeting carrier

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CHITOSAN; PREDNISOLONE HEMISUCCINATE; SUCCINIC ACID; DRUG CARRIER; PREDNISOLONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONJUGATION; CONTROLLED STUDY; COVALENT BOND; CYTOTOXICITY; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG RETENTION; DRUG SAFETY; DRUG TARGETING; DRUG TISSUE LEVEL; KIDNEY CELL; MALE; MEAN RESIDENCE TIME; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; ACETYLATION; ANIMAL; BIOAVAILABILITY; CELL LINE; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; KIDNEY; METABOLIC CLEARANCE RATE; METABOLISM; MOUSE STRAIN; PATHOLOGY; TISSUE DISTRIBUTION;

ACETYLATION; ANIMALS; BIOLOGICAL AVAILABILITY; CELL LINE; CELL SURVIVAL; CHITOSAN; DRUG CARRIERS; KIDNEY; MALE; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED STRAINS; MOLECULAR STRUCTURE; MOLECULAR WEIGHT; PREDNISOLONE; TISSUE DISTRIBUTION;

EID: 34447517621     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860701289875     Document Type: Article

References (36)

1. Begona, CG and Ruth, D. (1997) Evaluation of the biological properties of soluble chitosan and chitosan microspheres. Int J Pharm, 148, pp. 231-240.
2. Cai, Q. and Zhang, ZR (2005) Lectin-mediated cytotoxicity and specificity of 5-fluorouracil conjugated with peanut agglutinin (5-Fu-PNA) in vitro. J Drug Target, 13:4, pp. 251-257.
3. Czock, D., Keller, F., Rasche, FM and Haussler, U. (2005) Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet, 44:1, pp. 61-98.
4. Eaton, DC and Pooler, J. (2004) Renal blood flow and glomerular filtration. Lange medical books: Vander's renal physiology, pp. 24-37. McGraw Hill, New York
5. Ekrami, H., Kennedy, AR and Shen, WC (1995) Disposition of positively charged bowman-brik ptoease inhibitor conjugates in mice-influence of protein conjugate charge-density and size on lung targeting. J Pharm Sci, 84:4, pp. 456-461.
6. Hudecz, F., Remenyi, J., Szabo, R., Kocan, G., Mezo, G., Kovacs, P. and Gaal, D. (2003) Drug targeting by macromolecules without recognition unit?. J Mol Recognit, 16, pp. 288-298.
7. Folgert, R., Haverdings, G., Haas, M., Greupink, AR, de Vries, P Marcel, Moolenaar, F., Zeeuw, D. and Meijer, DKF (2001) Potentials and limitations of the low molecular-weight protein lysozyme as a carrier for renal drug targeting. Renal Failure, 23, pp. 397-409.
8. Friedman, AL and Chesney, RW (1982) Glucocorticoids in renal disease: Theoretical basis, consequences and efficacy of use in the pediatric patient. Am J Nephrol, 2:6, pp. 330-341.
9. Gupta, KC and Kumar, MNVR (2000) Drug release behavior of beads and microgranules of chitosan. Biomaterials, 20, pp. 1115-1119.
10. Haas, M., De Zeeuw, D., Van Zanten, A. and Meijer, DKF (1993) Quantification of renal low-molecular-weight protein handling in the intact rat. Kidney Int, 43, pp. 949-954.
11. Haas, M., Meijer, DKF and De Zeeuw, D. (2002) Specific drug delivery to the kidney. Cardiovas Drug Ther, 16, pp. 489-496.
12. Haga, HJ (1989) Kidney lysosomes. Int J Biochem, 21, pp. 343-345.
13. Kamada, H., Tsutsumi, Y., Kamada, KS, Yamamoto, Y., Yasuo, Y., Okamoto, T., Nakagawa, S., Nagata, S. and Mayumi, T. (2003) Synthesis of a poly (vinylpyrrolidone- co-dimethyl maleic anhydride) co-polymer and its application as renal targeting carrier. Nat Biotechnol, 21, pp. 399-404.
14. Kaneda, Y., Tsutsumi, Y., Yoshioka, Y., Kamada, H., Yamamoto, Y., Kodaira, H., Tsunoda, S., Okamoto, T., Mukai, Y., Shibata, H., Nakagawa, S. and Mayumi, T. (2004) The use of PVP as a polymeric carrier to improve the plasma half-life of drugs. Biomaterials, 25, pp. 3259-3266.
15. Kodaira, H., Tsutsumi, Y., Yoshioka, Y., Kamada, H., Kaneda, Y., Yamamoto, Y., Tsunoda, S., Okamoto, T., Mukai, Y., Shibata, H., Nakagawa, S. and Mayumi, T. (2004) The targeting of anionized polyvinylpyrrolidone to the renal system. Biomaterials, 25:18, pp. 4309-4315.
16. Kok, RJ, Grijpstra, F., Walthuis, RB, Moolenaar, F., De Zeeuw, D. and Meijer, DKF (1999) Specific delivery of captopril to the kidney with the prodrug captopril-lysozyme. J Pharmacol Exp Ther, 288, pp. 281-285.
17. Kubota, N. and Eguchi, Y. (1997) Facile preparation of water-soluble N-acetylated chitosan and molecular weight dependence of its water-solubility. Polym J, 29:2, pp. 123-127.
18. Kubota, N., Tatsumoto, N., Sano, T. and Toya, K. (2000) A simple preparation of half N-acetylated chitosan highly soluble in water and aqueous organic solvents. Carbohyd Res, 324, pp. 268-274.
19. Kurita, K., Koyama, Y., Nishimura, S. and Kamiya, M. (1989) Facile preparation of water-soluble chitin from chitosan. Chem Lett, 9, pp. 1597-1598.
20. Lee, KY, Ha, WS and Park, WH (1995) Blood compatibility and biodegradability of partially N-acylated chitosan derivatives. Biomaterials, 16, pp. 1211-1216.
21. Licha, K. and Olbrich, C. (2005) Optical imaging in drug discovery and diagnostic applications. Adv Drug Delivery Rev, 57, pp. 1087-1108.
22. Magee, MH, Blum, RA, Lates, CD and Jusko, WJ (2001) Prednisolone pharmacokinetics and pharmacodynamics in relation to sex and race. J Clin Pharm, 41:11, pp. 1180-1194.
23. Mehvar, R., Robinson, MA and Reynolds, JM (1994) Molecular weight dependent tissue accumulation of dextrans: In vivo studies in rats. J Pharm Sci, 83:10, pp. 1495-1499.
24. Moleod, AD, Friend, DR and Tozer, TN (1994) Glucocorticoid-dextran conjugates as potential prodrugs for colon-specific delivery: Hydrolysis in Rat gastrointestinal tract contents. J Pharm Sci, 83:9, pp. 1284-1288.
25. Okamoto, T., Nakagawa, S. and Tsutsumi, Y. (2004) The optimal molecular design of polymeric drug carriers and its application for renal drug targeting. Gene Ther Mol Biol, 8, pp. 221-230.
26. Onishi, H. and Machida, Y. (1999) Biodegradation and distribution of water-soluble chitosan in mice. Biomaterials, 20, pp. 175-182.
27. Pinaud, F., Michalet, X., Bentolila, LA, Tsay, JM, Doose, S., Li, JJ, Iyer, G. and Weiss, S. (2006) Advances in fluorescence imaging with quantum dot bio-probes. Biomaterials, 27:9, pp. 1679-1687.
28. Qin, CQ, Du, YM and Xiao, L. (2002) Effect of hydrogen peroxide treatment on the molecular weight and structure of chitosan. Polym Degrad Stabil, 76, pp. 211-218.
29. Rohatagi, S., Barth, J., Mollmann, H., Hochhau, SG, Soldner, A., Mollmann, C. and Derendorf, H. (1997) Pharmacokinetics of methylprednisolone and prednisolone after single and multiple oral administration. J Clin Pharm, 37:10, pp. 916-925.
30. Sannan, T., Kurita, K. and Iwakura, Y. (1976) Studies on chitin 2: Effect of deacetylation on solubility. Makromolekulare Chemie, 177:12, pp. 3589-3600.
31. Suntres, ZE and Shek, PN (1998) Liposomes promote pulmonary glucocorticoid delivery. J Drug Target, 6:3, pp. 175-182.
32. Suzuki, K., Susaki, H., Okuno, S. and Sugiyama, Y. (1999) Renal drug targeting using a vector "alkylglycoside". J Pharmacol Exp Ther, 288:1, pp. 57-64.
33. Suzuki, K., Susaki, H., Okuno, S., Yamada, H., Watanabe, HK and Sugiyama, Y. (1999) Specific renal delivery of sugar modified low-molecular-weight peptides. J Pharmacol Exp Ther, 288:2, pp. 888-897.
34. Wilk, S., Mizoguchi, H. and Orlowski, M. (1978) γ-Glutamyl dopa: A kidney-specific dopamine precursor. J Pharmacol Exp Ther, 206:1, pp. 227-232.
35. Yamamoto, Y., Tsutsumi, Y., Yoshioka, Y., Kamada, H., Kamada, KS, Okamoto, T., Mukai, Y., Shibata, H., Nakagawa, S. and Mayumi, T. (2004) Poly (vinylpyrrolidone-co- dimethylmaleic acid) as a novel renal targeting carrier. J Control Release, 95:2, pp. 229-237.
36. Yuan, Y., Zhang, PY, Yang, YM, Wang, XD and Gu, XS (2004) The interaction of Schwann cells with chitosan membranes and fibers in vitro. Biomaterials, 25:18, pp. 4273-4278.